Beijing SL Pharmaceutical Co., Ltd. (002038.SZ)
002038.SZ Stock Price Chart
Explore Beijing SL Pharmaceutical Co., Ltd. interactive price chart. Choose custom timeframes to analyze 002038.SZ price movements and trends.
002038.SZ Company Profile
Discover essential business fundamentals and corporate details for Beijing SL Pharmaceutical Co., Ltd. (002038.SZ) to support your stock research and investment decisions.
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
IPO Date
9 Sept 2004
Employees
856.00
Website
https://www.slpharm.com.cnCEO
Mingbo Xu
Description
Beijing SL Pharmaceutical Co., Ltd., a biopharmaceutical company, researches, develops, produces, and markets genetic engineering and related drugs in the People's Republic of China and internationally. The company's finished formulations includes temozolomide; arsenic trioxide; lenalidomide; docetaxel; paclitaxel; filgrastim Recombinant human granulocyte colony-stimulating factor; recombinant human interleukin-11; recombinant human interleukin-2; thymopentin; vinorelbine bitartrate; hydroxyl-camptothecine; nimustine hydrochloride; asparaginase; PEG L-asparaginase; calcium foliate; recombinant human basic fibroblast growth factor; ciclosporin; mycophenolate mofetil dispersible; ornidazole; adefovir dipivoxil; levofloxacin hydrochloride; azithromycin; ribavirin; tenofovir disoproxil fumarate; valacylovir hydrochloride; lysozyme; stavudine; tropisetron hydrochloride; granisetron hydrochloride; omeprazole; ademetionine 1,4-butanedisulfonate; glutathione; enoxaparin sodium; coenzyme complex; ginkgo biloba extract; simvastatin; telmisartan; naftopidil; nicergoline; zaleplon; cytidine disodium triphosphate; febuxostat; risedronate sodium; loratadine dispersible; somatostatin; octreotide acetate; calcitonin (salmon); paracetamol and tramadol hydrochloride; and etodolac. It also offers active pharmaceutical ingredients. The company was formerly known as Beijing BaiLuyuan Bio-Pharmaceutical Co., Ltd and changed its name to Beijing SL Pharmaceutical Co., Ltd. in 1998. Beijing SL Pharmaceutical Co., Ltd. was founded in 1994 and is based in Beijing, the People's Republic of China.
002038.SZ Financial Timeline
Browse a chronological timeline of Beijing SL Pharmaceutical Co., Ltd. corporate events including earnings releases, dividend announcements, and stock splits.
Dividend declared on 4 Jul 2025
A dividend of ¥0.02 per share was announced, adjusted to ¥0.02. The dividend was paid on 4 Jul 2025.
Earnings released on 31 Mar 2025
EPS came in at ¥0.04 , while revenue for the quarter reached ¥168.90M .
Earnings released on 31 Dec 2024
EPS came in at -¥0.05 , while revenue for the quarter reached ¥119.86M .
Earnings released on 30 Sept 2024
EPS came in at -¥0.05 , while revenue for the quarter reached ¥148.50M .
Dividend declared on 4 Jul 2024
A dividend of ¥0.15 per share was announced, adjusted to ¥0.15. The dividend was paid on 4 Jul 2024.
Earnings released on 29 Jun 2024
EPS came in at -¥0.04 , while revenue for the quarter reached ¥144.42M .
Earnings released on 23 May 2024
EPS came in at ¥0.07 , while revenue for the quarter reached ¥243.52M .
Earnings released on 30 Dec 2023
EPS came in at ¥0.10 , while revenue for the quarter reached ¥238.64M .
Earnings released on 30 Sept 2023
EPS came in at ¥0.00 , while revenue for the quarter reached ¥193.12M .
Earnings released on 30 Jun 2023
EPS came in at ¥0.11 , while revenue for the quarter reached ¥286.93M .
Dividend declared on 28 Jun 2023
A dividend of ¥0.10 per share was announced, adjusted to ¥0.10. The dividend was paid on 28 Jun 2023.
Earnings released on 31 Mar 2023
EPS came in at ¥0.20 , while revenue for the quarter reached ¥296.58M .
Earnings released on 1 Jan 2023
EPS came in at -¥0.00 , while revenue for the quarter reached ¥223.19M .
Earnings released on 30 Sept 2022
EPS came in at ¥0.07 , while revenue for the quarter reached ¥272.76M .
Earnings released on 30 Jun 2022
EPS came in at ¥0.10 , while revenue for the quarter reached ¥279.66M .
Dividend declared on 29 Jun 2022
A dividend of ¥0.10 per share was announced, adjusted to ¥0.10. The dividend was paid on 29 Jun 2022.
Earnings released on 28 Apr 2022
EPS came in at ¥0.06 , while revenue for the quarter reached ¥274.55M .
Earnings released on 25 Apr 2022
EPS came in at -¥0.01 , while revenue for the quarter reached ¥301.43M .
Earnings released on 29 Oct 2021
EPS came in at ¥0.21 , while revenue for the quarter reached ¥371.70M .
Earnings released on 30 Sept 2021
EPS came in at ¥0.13 , while revenue for the quarter reached ¥288.85M .
Dividend declared on 7 Jul 2021
A dividend of ¥0.10 per share was announced, adjusted to ¥0.10. The dividend was paid on 7 Jul 2021.
Earnings released on 31 Mar 2021
EPS came in at ¥0.09 , while revenue for the quarter reached ¥252.83M .
Earnings released on 26 Feb 2021
EPS came in at ¥0.05 , while revenue for the quarter reached ¥270.30M .
Earnings released on 30 Oct 2020
EPS came in at ¥0.10 , while revenue for the quarter reached ¥305.28M .
002038.SZ Stock Performance
Access detailed 002038.SZ performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.
Explore Related Stocks
Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.